News archive

Once again, the state of Rhineland-Palatinate has announced the research prize for the development of alternative and supplementary methods in accordance with the 3R principle of Russel and Burch (1959). Research institutions, companies or scientists based in Rhineland-Palatinate can apply.

A new website from the National Toxicology Program (NTP) makes it easy to search PubMed for literature on specific topics related to alternatives to animal testing (NAMs). NICEATM and the U.S. Department of Agriculture's Animal Welfare Information Center (AWIC) have jointly developed search strategies, called "hedges," for specific topics on alternatives.

TigerShark Science is a start-up currently being founded by the Fraunhofer Institute for Silicate Research ISC, based in Würzburg. The scientists want to significantly reduce animal testing with their skin models.

The congress of the European Society for Alternatives to Animal Testing (EUSAAT) will take place again this year from September 18 to 20, 2024. Abstracts can still be submitted until June 14, 2024.

On June 4, Charles River Laboratories International, Inc. has announced the launch of its Virtual Control Group (VCG) initiative in partnership with Sanofi. The two companies are working together to reduce the use of animals by replacing selected control group animals with appropriate virtual control animals developed from retrospective data sets.

As the non-profit organization FRAME (Fund for the Replacement of Animals in Medical Experiments) based in Nottigham has reported, numerous animal-free researchers are still being asked by editors of scientific journals to supplement resp. confirm their research results with animal experiments, even though these were not part of the study. Otherwise they would not be able to publish their research results there.

The Public-Private Platform for the Prevalidation of Methods to Characterize Endocrine Disruptors (PEPPER) is looking for partner laboratories.

Using large-scale genome-wide association studies, researchers have identified several genes that influence the risk of stroke and cardiovascular disease. Professor Martin Dichgans, Director of the Institute for Stroke and Dementia Research at LMU Hospital and a scientist in the SyNergy Cluster of Excellence, is convinced that genetic information can be used to identify potential targets for drug treatment.

Using the phage display method, Prof. Dr. Susanne Aileen Funke and her team from the Institute of Bioanalytics at Coburg University of Applied Sciences have discovered two new D-peptides, MMD3 and ISADI, which can alter the feared neuro-damaging aggregation of tau proteins.

Swedish researchers from Chalmers University of Technology and Gothenburg University have developed an AI method to better identify toxic chemicals based on molecular structure.

Page 1 of 86